Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Comment by Higherhopes2020on Jul 29, 2020 9:11am
129 Views
Post# 31335874

RE:next-superstock-online-investor-conference tomorrow vph

RE:next-superstock-online-investor-conference tomorrow vph

Valeo Pharma Applies for Listing on the U.S. OTCQB Market

https://stockhouse.com/news/press-releases/2020/07/29/valeo-pharma-applies-for-listing-on-the-u-s-otcqb-market


https://www.wallstreetreporter.com/next-superstock-online-investor-conference/

Steve Saviuk, CEO


Valeo Pharma (CSE: VPH) is a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. 

 

Click here to join July 29 NEXT SUPER STOCK livestream

Our recent presenters, NEXCF, CYDY, IPNFF have each increased: 1,200%, 1,4000% & 2,000% since first being featured on NEXT SUPER STOCK.

CLICK HERE to Join our livestreams and discover the next potential

10X-100X Super Stock!

[/quote]

<< Previous
Bullboard Posts
Next >>